A larger waist circumference is associated with a higher risk of all-cause mortality and decreased life expectancy. Meanwhile ...

Meanwhile, the group taking Zepbound (sold as Mounjaro for weight loss in some markets ... for people living with obesity and ...

Participants achieved an average weight loss of 20.2% with Zepbound vs. 13.7% with Wegovy ... and equip healthcare providers with critical insights to make well-informed treatment decisions ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical ...

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...

findings from a real-world electronic medical record study found adults with obesity using tirzepatide (Zepbound, Eli Lilly) were more likely to lose 5%, 10% or 15% of their body weight than those ...

If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your ...

As weight loss injections continue to ... well-known medications is providing some insight on the question: Which one is best? What are the details of the study? Researchers studied results for those ...

Eli Lilly announced that its obesity therapy Zepbound delivered superior outcomes versus Novo Nordisk’s Wegovy across five ...

This article was provided by Mary Washington Healthcare, a corporate sponsor of the Fredericksburg Free Press. As part of its ...